Pelvic Inflammatory Disease in COVID-19 Era
- Conditions
- Pelvic Inflammatory Disease
- Interventions
- Other: impact of COVID-19 on Health-Seeking Behaviors
- Registration Number
- NCT05648747
- Lead Sponsor
- Università degli Studi di Ferrara
- Brief Summary
The goal of this retrospective cohort study is to to scrutinize the impact of coronavirus disease 2019 (COVID-19) on incidence, demography and patient characteristics in Pelvic Inflammatory Disease comparing with the equal time duration, before and after lockdown was initiated in the country.
The main aim of this study was to compare the demographic and clinical parameters between two cohorts before the onset of lockdown and within the pandemic.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 300
Pelvic Inflammatory disease
Pregnancy Oncologic disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Non-Complicated Pelvic Inflammatory Disease impact of COVID-19 on Health-Seeking Behaviors No development of complicated Pelvic Inflammatory Disease diagnosed during laparoscopy or by pre-operative image study Complicated Pelvic Inflammatory Disease impact of COVID-19 on Health-Seeking Behaviors The development of complicated Pelvic Inflammatory Disease diagnosed during laparoscopy or by pre-operative image study
- Primary Outcome Measures
Name Time Method Incidence of pelvic inflammatory disease (PID) baseline, pre-surgery The primary outcome measure was the occurrence of PID defined as abscess observed in computed tomography or a description of gangrenous salpingitis assessed by pathological reports.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Section of Obstetrics and Gynecology, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy
🇮🇹Ferrara, Italy